Valoración del libro
Más información sobre el libro
The 45th edition of the leading reference on treatment of infectious diseases and anti-infective drug information. Available in print in pocket size, spiral bound and large library editions. New material and areas of significant change in this 45th edition include: * HCV treatment (Table 14G): Expanded treatment options using the newest direct acting agents (DAA) for interferon-free therapy based on the latest guidelines. * Parasitic diseases (Table 13A): Treatment of parasitic diseases has been comprehensively updated. * Antiretroviral therapy (Table 14): New once daily single tablet regimens have been added. * Antibacterial drug information (Table 9, Table 10): Pharmacology data and adverse effects summary have been extensively updated. * Resistant Bacteria (Tables 1, 5, & 6): Updates reflect the latest data and treatment options, including new agents for treatment of resistant S. aureus. -- Publisher
Compra de libros
The Sanford guide to antimicrobial therapy 2015, Autores varios
- Idioma
- Publicado en
- 2015
- product-detail.submit-box.info.binding
- (Tapa blanda)
Métodos de pago
Nos falta tu reseña aquí
- Título
- The Sanford guide to antimicrobial therapy 2015
- Idioma
- Inglés
- Autores
- Autores varios
- Publicado en
- 2015
- Formato
- Tapa blanda
- Páginas
- 238
- ISBN10
- 1930808844
- ISBN13
- 9781930808843
- Serie
- Etiquetas
- No ficción, Libros de texto, Salud & Medicina, Medicina, Guías y Manuales, Medicina
- Calificación
- 4,45 de 5
- Descripción
- The 45th edition of the leading reference on treatment of infectious diseases and anti-infective drug information. Available in print in pocket size, spiral bound and large library editions. New material and areas of significant change in this 45th edition include: * HCV treatment (Table 14G): Expanded treatment options using the newest direct acting agents (DAA) for interferon-free therapy based on the latest guidelines. * Parasitic diseases (Table 13A): Treatment of parasitic diseases has been comprehensively updated. * Antiretroviral therapy (Table 14): New once daily single tablet regimens have been added. * Antibacterial drug information (Table 9, Table 10): Pharmacology data and adverse effects summary have been extensively updated. * Resistant Bacteria (Tables 1, 5, & 6): Updates reflect the latest data and treatment options, including new agents for treatment of resistant S. aureus. -- Publisher